Connect with us

Health

Explainer: What’s known about ‘stealth’ version of omicron?

Scientists and health officials around the world are keeping their eyes on a descendant of the omicron variant that has been found in at least 40 countries, including the US.

For the latest headlines, follow our Google News channel online or via the app.

This version of the coronavirus, which scientists call BA.2, is widely considered stealthier than the original version of omicron because particular genetic traits make it somewhat harder to detect. Some scientists worry it could also be more contagious.

But they say there’s a lot they still don’t know about it, including whether it evades vaccines better or causes more severe disease.

WHERE HAS IT SPREAD?

Since mid-November, more than three dozen countries have uploaded nearly 15,000 genetic sequences of BA.2 to GISAID, a global platform for sharing coronavirus data. As of Tuesday morning, 96 of those sequenced cases came from the U.S.

“Thus far, we haven’t seen it start to gain ground” in the US, said Dr. Wesley Long, a pathologist at Houston Methodist in Texas, which has identified three cases of BA.2.

The mutant appears much more common in Asia and Europe. In Denmark, it made up 45 percent of all COVID-19 cases in mid-January, up from 20 percent two weeks earlier, according to Statens Serum Institut, which falls under the Danish Ministry of Health.

WHAT’S KNOWN ABOUT THIS VERSION OF THE VIRUS?

BA.2 has lots of mutations. About 20 of them in the spike protein that studs the outside of the virus are shared with the original omicron. But it also has additional genetic changes not seen in the initial version.

It’s unclear how significant those mutations are, especially in a population that has encountered the original omicron, said Dr. Jeremy Luban, a virologist at the University of Massachusetts Medical School.

For now, the original version, known as BA.1, and BA.2 are considered subsets of omicron. But global health leaders could give it its own Greek letter name if it is deemed a globally significant “variant of concern.”

The quick spread of BA.2 in some places raises concerns it could take off.

“We have some indications that it just may be as contagious or perhaps slightly more contagious than (original) omicron since it’s able to compete with it in some areas,” Long said. “But we don’t necessarily know why that is.”

An initial analysis by scientists in Denmark shows no differences in hospitalizations for BA.2 compared with the original omicron. Scientists there are still looking into this version’s infectiousness and how well current vaccines work against it. It’s also unclear how well treatments will work against it.

Doctors also don’t yet know for sure if someone who’s already had COVID-19 caused by omicron can be sickened again by BA.2. But they’re hopeful, especially that a prior omicron infection might lessen the severity of disease if someone later contracts BA.2.

The two versions of omicron have enough in common that it’s possible that infection with the original mutant “will give you cross-protection against BA.2,” said Dr. Daniel Kuritzkes, an infectious diseases expert at Brigham and Women’s Hospital.

Scientists will be conducting tests to see if antibodies from an infection with the original omicron “are able to neutralize BA.2 in the laboratory and then extrapolate from there,” he said.

HOW CONCERNED ARE HEALTH AGENCIES?

The World Health Organization classifies omicron overall as a variant of concern, its most serious designation of a coronavirus mutant, but it doesn’t single out BA.2 with a designation of its own. Given its rise in some countries, however, the agency says investigations of BA.2 “should be prioritized.”

The UK Health Security Agency, meanwhile, has designated BA.2 a “variant under investigation,” citing the rising numbers found in the UK and internationally. Still, the original version of omicron remains dominant in the UK.

WHY IS IT HARDER TO DETECT?

The original version of omicron had specific genetic features that allowed health officials to rapidly differentiate it from delta using a certain PCR test because of what’s known as “S gene target failure.”

BA.2 doesn’t have this same genetic quirk. So on the test, Long said, BA.2 looks like delta.

“It’s not that the test doesn’t detect it; it’s just that it doesn’t look like omicron,” he said. “Don’t get the impression that ‘stealth omicron’ means we can’t detect it. All of our PCR tests can still detect it.”

WHAT SHOULD YOU DO TO PROTECT YOURSELF?

Doctors advise the same precautions they have all along: Get vaccinated and follow public health guidance about wearing masks, avoiding crowds and staying home when you’re sick.

“The vaccines are still providing good defense against severe disease, hospitalization and death,” Long said. “Even if you’ve had COVID 19 before — you’ve had a natural infection — the protection from the vaccine is still stronger, longer lasting and actually … does well for people who’ve been previously infected.”

The latest version is another reminder that the pandemic hasn’t ended.

“We all wish that it was over,” Long said, “but until we get the world vaccinated, we’re going to be at risk of having new variants emerge.”

Read more:

Global oil demand expected to remain ‘robust’ despite COVID omicron variant: OPEC

WHO sees more evidence that omicron causes milder symptoms

Soaring omicron could lead to more dangerous variants, WHO warns

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

World News in Brief: Vaccine ‘patches’ trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation

Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots.

Continue Reading

Health

No sign yet of H5N1 bird flu spreading between humans, says WHO chief

The H5N1 avian influenza virus has so far shown no signs of adapting to allow human to human transmission, the UN health agency said on Wednesday, urging continued surveillance.

Continue Reading

Health

Patients in Rafah ‘afraid to seek services’, WHO reports

The World Health Organization (WHO) has taken “crucial steps” in the event of a large-scale Israeli military operation in Rafah, Dr. Ahmed Dahir, Team Lead of its office in Gaza, told UN News on Tuesday.

Continue Reading

Trending